On Aug. 20, 2019, Bayer announced that it has entered into a definitive agreement with US-based Elanco Animal Health to sell its Animal Health business to Elanco in a transaction valued at $7.6 billion. The purchase price consists of $5.3 billion in cash, subject to customary purchase price adjuOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.